Author	Contributions	Disclosures
Crockett	study concept and design; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content	Research funding from Exact Sciences, ColoWrap, and Boston Scientific.
Barry	acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content	None
Mott	acquisition of data; statistical analysis; analysis and interpretation of data; critical revision of the manuscript for important intellectual content; technical support	None
Ahnen	Site PI of original study; critical revision of the manuscript for important intellectual content	Scientific Advisory Board for Cancer Prevention Pharmaceuticals, Speakers Bureau for Ambry Genetics
Robertson	clinical director of original study, critical revision of the manuscript for important intellectual content	Scientific Advisory Board for Medtronic and Consultant for Freenome
Anderson	Critical revision of the manuscript for important intellectual content	None
Wallace	Critical revision of the manuscript for important intellectual content	None
Burke	Critical revision of the manuscript for important intellectual content	Research funding from Cancer Prevention Pharmaceuticals
Bresalier	Critical revision of the manuscript for important intellectual content	None
Figueiredo	Critical revision of the manuscript for important intellectual content	None
Snover	pathologist for original study; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content	None
Baron	study concept and design; obtained funding; administrative and material support; analysis and interpretation of data; critical revision of the manuscript for important intellectual content; study supervision	Together with Dartmouth College, Dr. Baron holds a use patent for the chemopreventive use of calcium, currently not licensed.